Federated Hermes, Inc. Adicet Bio, Inc. Transaction History

Federated Hermes, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$1.21 - $2.4 $1,395 - $2,767	1,153 New	1,153 $1,000
Q4 2023 Jan 31, 2024	BUY	$1.11 - $1.89 $1,199 - $2,043	1,081 Added 46.16%	3,423 $6,000
Q3 2023 Nov 13, 2023	BUY	$1.37 - $3.4 $2,819 - $6,997	2,058 Added 724.65%	2,342 $3,000
Q2 2023 Aug 14, 2023	BUY	$2.13 - $7.13 $604 - $2,024	284 New	284 $0
Q1 2021 May 13, 2021	SELL	$12.12 - $17.17 $715 - $1,013	-59 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$10.36 - $14.77 $2,092 - $2,983	-202 Reduced 77.39%	59 $1,000
Q3 2020 Nov 12, 2020	BUY	$10.18 - $21.4 $2,656 - $5,585	261 New	261 $3,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $38M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.